Intensity Therapeutics (INTS) awards director 5,500 options at $4.90 strike
Rhea-AI Filing Summary
Intensity Therapeutics, Inc. reported that director Thomas I H Dubin was granted a stock option to acquire 5,500 shares of Common Stock at an exercise price of $4.90 per share. The option expires on July 16, 2036 and will vest in four equal annual installments beginning July 16, 2026, subject to his continued service with the company. Following this grant, he directly holds options for 5,500 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
DUBIN THOMAS I H
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy Common Stock) F1 | 5,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy Common Stock) — 5,500 shares (Direct)
Footnotes (1)
- F1. This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026.
Key Figures
Options Granted: 5,500 options
Exercise Price: $4.90 per share
Expiration Date: July 16, 2036
+3 more
6 metrics
Options Granted
5,500 options
Stock option grant to director Thomas I H Dubin on July 16, 2026
Exercise Price
$4.90 per share
Conversion or exercise price of the granted stock option
Expiration Date
July 16, 2036
Expiration of the director’s stock option grant
Underlying Shares
5,500 shares
Common Stock underlying the granted stock option
Vesting Start Date
July 16, 2026
First vesting date; four equal annual installments, subject to continued service
Post-Grant Holdings
5,500 options
Total derivative securities held by the director after the grant
Key Terms
Stock Option, exercise price, expiration date, vesting
4 terms
Stock Option financial
"Stock Option (right to buy Common Stock)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "4.9000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-07-16""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"This option will vest, subject to the individual's continued service"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did INTENSITY THERAPEUTICS (INTS) report for Thomas I H Dubin?
Intensity Therapeutics reported that director Thomas I H Dubin received a grant of 5,500 stock options to buy Common Stock at $4.90 per share, expiring July 16, 2036, as part of his director compensation.
What is the exercise price and term of the new INTENSITY THERAPEUTICS (INTS) stock option?
The stock option granted to the director has an exercise price of $4.90 per share and an expiration date of July 16, 2036. This defines the price he may pay and the last date on which he can exercise the option.
How do the INTENSITY THERAPEUTICS (INTS) options granted to the director vest?
The option granted to the director will vest in four equal annual installments, beginning on July 16, 2026. Vesting is explicitly conditioned on his continued service with Intensity Therapeutics for each annual installment date.
What is the director’s INTENSITY THERAPEUTICS (INTS) option position after this grant?
After the reported transaction, the director directly holds 5,500 stock options for Intensity Therapeutics Common Stock. This figure reflects his total option holdings reported in this insider transaction, following the new grant on July 16, 2026.
Is the INTENSITY THERAPEUTICS (INTS) option grant a market purchase or a compensation award?
The transaction is coded as a grant, award, or other acquisition of a derivative security, indicating a compensation-related stock option award to the director, not an open-market purchase of existing Intensity Therapeutics shares.